This webinar will examine recent enforcement developments and trends relevant to pharmaceutical and medical device manufacturers in the evolving paradigm of COVID-19. Nearly two years after the first cases of the novel coronavirus were detected, the pharmaceutical and medical device industries—and the vaccines brought to market across the globe—continue to dominate newspaper headlines. With a new presidential administration in the United States, and new leadership at the Department of Justice, this presentation will review recent DOJ statements, settlement announcements and ongoing litigation to provide in-house counsel with perspective on the post-COVID-19 enforcement world and what to expect going forward.
If you have questions concerning this roundtable webinar, email Chayako Williams at email@example.com.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, firstname.lastname@example.org. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.